Re: Christopher D. Gaffney, Andrew Katims, Neeta D'Souza, Marc A. Bjurlin, Richard S. Matulewicz. Bladder Cancer Carcinogens: Opportunities for Risk Reduction. Eur Urol Focus 2023;9:575–8

Yu Hsiang Lin; Han Yu Tsai; Horng Heng Juang

doi:10.1016/j.euf.2023.11.015

Re: Christopher D. Gaffney, Andrew Katims, Neeta D'Souza, Marc A. Bjurlin, Richard S. Matulewicz. Bladder Cancer Carcinogens: Opportunities for Risk Reduction. Eur Urol Focus 2023;9:575–8

Yu Hsiang Lin^*, Han Yu Tsai, Horng Heng Juang

^*此作品的通信作者

長庚大學

研究成果: 期刊稿件 › 快報 › 同行評審

原文	英語
頁（從 - 到）	242-243
頁數	2
期刊	European urology focus
卷	10
發行號	2
早期上線日期	25 01 2024
DOIs	https://doi.org/10.1016/j.euf.2023.11.015
出版狀態	已出版 - 03 2024

UN SDG

此研究成果有助於以下永續發展目標

存取文件

10.1016/j.euf.2023.11.015

其它文件與鏈接

Link to publication in Scopus

引用此

@article{f2bcc09a8bb84d2297b5a2eb3059df10,

title = "Re: Christopher D. Gaffney, Andrew Katims, Neeta D'Souza, Marc A. Bjurlin, Richard S. Matulewicz. Bladder Cancer Carcinogens: Opportunities for Risk Reduction. Eur Urol Focus 2023;9:575–8",

keywords = "Carcinogens, Humans, Risk Reduction Behavior, Urinary Bladder Neoplasms",

author = "Lin, {Yu Hsiang} and Tsai, {Han Yu} and Juang, {Horng Heng}",

year = "2024",

month = mar,

doi = "10.1016/j.euf.2023.11.015",

language = "英语",

volume = "10",

pages = "242--243",

journal = "European urology focus",

issn = "2405-4569",

publisher = "Elsevier B.V.",

number = "2",

}

TY - JOUR

T1 - Re

T2 - Christopher D. Gaffney, Andrew Katims, Neeta D'Souza, Marc A. Bjurlin, Richard S. Matulewicz. Bladder Cancer Carcinogens: Opportunities for Risk Reduction. Eur Urol Focus 2023;9:575–8

AU - Lin, Yu Hsiang

AU - Tsai, Han Yu

AU - Juang, Horng Heng

PY - 2024/3

Y1 - 2024/3

KW - Carcinogens

KW - Humans

KW - Risk Reduction Behavior

KW - Urinary Bladder Neoplasms

UR - http://www.scopus.com/inward/record.url?scp=85184753457&partnerID=8YFLogxK

U2 - 10.1016/j.euf.2023.11.015

DO - 10.1016/j.euf.2023.11.015

M3 - 快报

C2 - 38278712

AN - SCOPUS:85184753457

SN - 2405-4569

VL - 10

SP - 242

EP - 243

JO - European urology focus

JF - European urology focus

IS - 2

ER -